RenovoRx shareholders elect directors, approve equity plan amendment, ratify auditor

RenovoRx, Inc.

All six director nominees elected; three directors received >3.2M withheld votes each.
Equity plan amended: 913,794 shares added (2.5% of outstanding); evergreen increased from 3% to 5%.
Ratification of Frank, Rimerman + Co. as auditor for FY2025 passed with 19.13M votes for, 949K against.
Approximately 20.09M shares voted out of 36.55M outstanding, constituting a quorum.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.